1978 1980 1981 1982 1983 1984

1985 1986 1987 1988 1989 1990

1992 1993 1994 1995 1996 1997

1998 1999 2000 2001 2002 2003

2004 2005 2006 2007 2008

Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006.
Bostwick DG, Waters DJ, Farley ER, Meiers I, Rukstalis D, Cavanaugh WA, Ragde H, Dineen MK, Bahn D, Scionti S, Babian R, Ellis DS, Rewcastle JC, Burke HB, Andriole GL, Onik G, Barqawi AE, Maksem J, Barzell WE.

Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007.
Meiers I, Waters DJ, Bostwick DG.

Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach.
Andriole GL, Bullock TL, Belani JS, Traxel E, Yan Y, Bostwick DG, Humphrey PA.

The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial.
Nickel JC, Roehrborn CG, O'Leary MP, Bostwick DG, Somerville MC, Rittmaster RS.

Over-diagnosis of high-grade prostatic intraepithelial neoplasia: a prospective study of 251 cases.
Bostwick DG, Ma J.

Improved filter method for urine sediment detection of urothelial carcinoma by fluorescence in situ hybridization.
Meiers I, Singh H, Hossain D, Lang K, Liu L, Qian J, Verhest AP, Bostwick DG.

Noninvasive prediction of prostatic DNA damage by oxidative stress challenge of peripheral blood lymphocytes.
Waters DJ, Shen S, Xu H, Kengeri SS, Cooley DM, Chiang EC, Chen Y, Schlittler D, Oteham C, Combs GF Jr, Glickman LT, Morris JS, Bostwick DG.

Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.
Liu L, Qian J, Singh H, Meiers I, Zhou X, Bostwick DG.

Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer.
Venkataraman G, Heinze G, Holmes EW, Ananthanarayanan V, Bostwick DG, Paner GP, Bradford-De La garza CM, Brown HG, Flanigan RC, Wojcik EM.

Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.
Nickel JC, Roehrborn CG, O'leary MP, Bostwick DG, Somerville MC, Rittmaster RS.

Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.
Meiers I, Shanks JH, Bostwick DG.

Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma.
Bostwick DG, Meiers I, Shanks JH.

Diagnosis of prostatic carcinoma after therapy.
Bostwick DG, Meiers I.

Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate.
Wang X, Jones TD, Zhang S, Eble JN, Bostwick DG, Qian J, Lopez-Beltran A, Montironi R, Harris JJ, Cheng L.